Three Cases of Combined Therapy in Primary Breast Lymphoma (PBL) with Successful Outcomes

Autor: Zorka Inic, Momcilo Inic, Milan Zegarac, Ivana Inic, Gordana Pupic

Publikováno v: Clinical Medicine Insights: Oncology, Vol 2013, Iss 7, Pp 159-163 (2013)

Externí odkaz: https://doaj.org/article/4045d68fdb524e8fa888190c59c71fd5

The relationship between proliferation activity and parathyroid hormone levels in parathyroid tumors

Autor: Zorka, Inic, Momcilo, Inic, Snezana, Jancic, Ivan, Paunovic, Svetislav, Tatic, Katarina, Tausanovic, Vladan, Zivavljevic, Milan, Zegarac, Ivana, Inic, Dusko, Dunjdjerovic

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(2)

This article examines as to whether the Ki-67 index may be useful as a marker for cell proliferation, as well as to whether Ki-67 immunohistochemical expression and parathyroid hormone (PTH) levels are useful in distinguishing between parathyroid car

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e5392002f4714cc746363b390efe93a7
https://pubmed.ncbi.nlm.nih.gov/26011350

Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information

Autor: Ivan Markovic, Zoran Kozomara, Gordana Pupic, Milan Zegarac, Snezana Jancic, Igor Djurisic, Ivana Inic, Momcilo Inic, Zorka Inic

Publikováno v: Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 8 (2014)
Clinical Medicine Insights: Oncology, Vol 2014, Iss 8, Pp 107-111 (2014)

Background The St. Gallen International Expert Consensus of 2011 proposes a new classification system for breast cancer based on its division into five subgroups. The criteria to identify these subtypes were recently refined at the 2013 Conference. I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ad7fbbfd095800b5b29cca4154905a
https://doi.org/10.4137/cmo.s18006

Three Cases of Combined Therapy in Primary Breast Lymphoma (PBL) with Successful Outcomes

Autor: Gordana Pupic, Zorka Inic, Ivana Inic, Milan Zegarac, Momcilo Inic

Publikováno v: Clinical Medicine Insights: Oncology, Vol 2013, Iss 7, Pp 159-163 (2013)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 7 (2013)

Primary malignant lymphoma of the breast is a rare tumor, defined as a tumor localized in the breast with or without axillary lymph-node metastases. Such a tumor is mainly found in female patients and located more frequently in the right breast. It i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833480ba15f0ad9791cee6e7a7714aa3
https://doi.org/10.4137/cmo.s12044

BRAF V600E MUTATIONS IN METASTATIC MELANOMA - CASE REPORT

Autor: Ivana Inić, Momcilo Inić, Zorka Inić, Milan Zegarac, Aleksandar Martinović, Miomir Šašić, Miloš Bracanović, Gordana Pupić

Publikováno v: Acta Medica Medianae, Vol 53, Iss 3, Pp 39-41 (2014)

The treatment of metastatic melanoma represents a challenge. Vemurafenib, a selective BRAF kinase inhibitor, is a new medicine against carcinoma. Recently, it has been shown that it raises the survival rate among patients with metastatic melanoma who

Externí odkaz: https://doaj.org/article/5228c4373799444ebccd9d6eee2a08db